ATE79114T1 - Aromatische und heterocyclische carboxamide als antineoplastische mittel. - Google Patents

Aromatische und heterocyclische carboxamide als antineoplastische mittel.

Info

Publication number
ATE79114T1
ATE79114T1 AT89305141T AT89305141T ATE79114T1 AT E79114 T1 ATE79114 T1 AT E79114T1 AT 89305141 T AT89305141 T AT 89305141T AT 89305141 T AT89305141 T AT 89305141T AT E79114 T1 ATE79114 T1 AT E79114T1
Authority
AT
Austria
Prior art keywords
aromatic
antineoplastic agents
heterocyclic carboxamides
carboxamides
heterocyclic
Prior art date
Application number
AT89305141T
Other languages
English (en)
Inventor
Anton Franz Josef Fliri
Rodney Caughren Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE79114T1 publication Critical patent/ATE79114T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Graft Or Block Polymers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89305141T 1988-05-24 1989-05-22 Aromatische und heterocyclische carboxamide als antineoplastische mittel. ATE79114T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19803488A 1988-05-24 1988-05-24
EP89305141A EP0343893B1 (de) 1988-05-24 1989-05-22 Aromatische und heterocyclische Carboxamide als antineoplastische Mittel

Publications (1)

Publication Number Publication Date
ATE79114T1 true ATE79114T1 (de) 1992-08-15

Family

ID=22731735

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89305141T ATE79114T1 (de) 1988-05-24 1989-05-22 Aromatische und heterocyclische carboxamide als antineoplastische mittel.

Country Status (25)

Country Link
EP (1) EP0343893B1 (de)
JP (1) JPH0678331B2 (de)
KR (1) KR910006864B1 (de)
CN (1) CN1023700C (de)
AT (1) ATE79114T1 (de)
AU (1) AU601905B2 (de)
CA (1) CA1328871C (de)
DD (1) DD283815A5 (de)
DE (1) DE68902358T2 (de)
DK (1) DK249389A (de)
ES (1) ES2043012T3 (de)
FI (1) FI892498A7 (de)
GR (1) GR3005844T3 (de)
HU (1) HU202507B (de)
IE (1) IE891667L (de)
IL (1) IL90337A0 (de)
MX (1) MX173140B (de)
MY (1) MY106035A (de)
NO (1) NO172389C (de)
NZ (1) NZ229234A (de)
PL (1) PL154875B1 (de)
PT (1) PT90622B (de)
SU (1) SU1681728A3 (de)
YU (1) YU47019B (de)
ZA (1) ZA893862B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2790299B2 (ja) * 1989-02-01 1998-08-27 保土谷化学工業株式会社 ペンゾチアゾール誘導体
US5262400A (en) * 1991-06-20 1993-11-16 Merck & Co., Inc. 4α-substituted avermectin derivatives
AU702487B2 (en) * 1995-08-30 1999-02-25 G.D. Searle & Co. Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
US5716281A (en) * 1995-11-27 1998-02-10 Sega Enterprises, Ltd. Game apparatus using a vehicle with an optical image synthesizing system
TW513418B (en) * 1996-07-31 2002-12-11 Otsuka Pharma Co Ltd Thiazole derivatives, their production and use
ES2256969T3 (es) 1997-11-10 2006-07-16 Bristol-Myers Squibb Company Compuestos de benzotiazol inhibidores de proteina tirosina qauinasa.
EP0928793B1 (de) * 1998-01-02 2002-05-15 F. Hoffmann-La Roche Ag Thiazol-Derivate
AU3406599A (en) * 1998-04-09 1999-11-01 Institut Fur Diagnostikforschung Gmbh An Der Freien Universitat Berlin Novel benzyl guanidine derivatives for therapy and (in-vivo) and (in-vitro) diagnosis
KR100526487B1 (ko) 2000-06-21 2005-11-08 에프. 호프만-라 로슈 아게 벤조티아졸 유도체
US6620811B2 (en) * 2001-11-19 2003-09-16 Hoffmann-La Roche Inc. Isonicotin- and nicotinamide derivatives of benzothiazoles
US6599901B1 (en) * 2001-11-19 2003-07-29 Hoffman-La Roche Inc. Pyridone substituted benzothiazole derivatives
US6624163B2 (en) 2001-11-29 2003-09-23 Hoffman-La Roche Inc. Benzothiazole derivatives
GB0130868D0 (en) 2001-12-24 2002-02-06 Univ Strathclyde New compounds
CN100357283C (zh) * 2002-04-02 2007-12-26 中国科学院上海药物研究所 一类甲硫氨酰氨肽酶抑制剂
US7087761B2 (en) 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
MXPA05012120A (es) * 2003-05-13 2006-02-08 Hoffmann La Roche 2-imidazo-benzotiazoles como ligandos de receptores de adenosina.
ATE389652T1 (de) * 2003-05-19 2008-04-15 Hoffmann La Roche Benzothiazol-derivate als liganden des adenosinrezeptors
AU2004241720B2 (en) * 2003-05-21 2008-11-06 F. Hoffmann-La Roche Ag Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine A2A receptor
ATE396726T1 (de) * 2003-05-30 2008-06-15 Hoffmann La Roche Benzothiazole derivate und ihre anwendung in der behandlung von adenosine a2a rezeptor vermittelte krankheiten
SI1660492T1 (sl) * 2003-07-28 2009-02-28 Janssen Pharmaceutica Nv Benzimidazolni, benztiazolni in benzoksazolni derivati in njihova uporaba kot modulatorji LTA4H
EP1753760B1 (de) 2004-05-24 2008-01-02 F.Hoffmann-La Roche Ag 4-hydroxy-4-methylpiperidin-1-carbonsäure-(4-methoxy-7-morpholin-4-ylbenzothiazol-2-yl)-amid
ES2339867T3 (es) * 2004-07-22 2010-05-26 F. Hoffmann-La Roche Ag Derivados de benzotiazol.
EP1773795A1 (de) * 2004-07-22 2007-04-18 F.Hoffmann-La Roche Ag Substituierte benzothiazole
EP1812392B1 (de) 2004-11-05 2008-07-09 F.Hoffmann-La Roche Ag Verfahren zur herstellung von isonikotinsäurederivaten
CN101180299B (zh) 2005-03-23 2010-12-15 弗·哈夫曼-拉罗切有限公司 作为mglur2拮抗剂的乙炔基-吡唑并嘧啶衍生物
BRPI0616571A2 (pt) 2005-09-27 2011-06-21 Hoffmann La Roche oxadiazolil pirazol-piridiminas como antagonistas de mglur2, processo para sua preparação, composição farmacêutica que os contém e uso dos mesmo
CN101405278A (zh) * 2006-03-15 2009-04-08 4Sc股份公司 新颖的杂环NF-κB抑制剂
GB0619325D0 (en) 2006-09-30 2006-11-08 Univ Strathclyde New compounds
EP2311842A3 (de) * 2008-06-24 2011-07-13 Takeda Pharmaceutical Company Limited PI3K/M TOR Inhibitoren
US9499790B2 (en) 2010-08-26 2016-11-22 Kyoto University Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells
WO2013049407A2 (en) * 2011-09-30 2013-04-04 Kineta, Inc Anti-viral compounds
WO2013111875A1 (ja) 2012-01-27 2013-08-01 国立大学法人京都大学 多能性幹細胞の心筋分化誘導法
JP6351567B2 (ja) 2013-03-08 2018-07-04 国立大学法人京都大学 Ｅｇｆ受容体阻害剤を含む多能性幹細胞の心筋分化促進剤
JP6333830B2 (ja) * 2013-09-13 2018-05-30 国立大学法人京都大学 多能性幹細胞の心筋分化を促進する化合物
US10233426B2 (en) 2014-05-30 2019-03-19 Kyoto University Method for inducing cardiac differentiation of pluripotent stem cell with low-molecular compounds
CN109776486A (zh) * 2019-02-26 2019-05-21 武汉松石科技股份有限公司 一种硫酸亚丙酯的制备方法
CN110590735B (zh) * 2019-09-30 2021-07-23 江苏国泰超威新材料有限公司 一种环状硫酸酯的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61225168A (ja) * 1985-03-30 1986-10-06 Nippon Tokushu Noyaku Seizo Kk 新規ベンズアミド、その製法及び殺虫剤
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
GB8611606D0 (en) * 1986-05-13 1986-06-18 Fbc Ltd Fungicides

Also Published As

Publication number Publication date
CN1023700C (zh) 1994-02-09
NO172389C (no) 1993-07-14
DD283815A5 (de) 1990-10-24
FI892498A0 (fi) 1989-05-23
HUT51606A (en) 1990-05-28
MX16158A (es) 1993-06-01
JPH0678331B2 (ja) 1994-10-05
DK249389D0 (da) 1989-05-23
PL279613A1 (en) 1989-11-27
NO892059L (no) 1989-11-27
MX173140B (es) 1994-02-02
MY106035A (en) 1995-03-31
EP0343893A1 (de) 1989-11-29
NZ229234A (en) 1990-09-26
FI892498A7 (fi) 1989-11-25
IE891667L (en) 1989-11-24
ES2043012T3 (es) 1993-12-16
DE68902358D1 (de) 1992-09-10
NO892059D0 (no) 1989-05-23
CA1328871C (en) 1994-04-26
YU105989A (en) 1990-08-31
DE68902358T2 (de) 1992-12-10
NO172389B (no) 1993-04-05
GR3005844T3 (de) 1993-06-07
KR910006864B1 (ko) 1991-09-09
EP0343893B1 (de) 1992-08-05
ZA893862B (en) 1991-01-30
PT90622B (pt) 1994-10-31
IL90337A0 (en) 1989-12-15
PL154875B1 (en) 1991-09-30
HU202507B (en) 1991-03-28
CN1037898A (zh) 1989-12-13
YU47019B (sh) 1994-11-15
JPH0217181A (ja) 1990-01-22
AU601905B2 (en) 1990-09-20
DK249389A (da) 1989-11-27
AU3509889A (en) 1989-11-30
KR890017248A (ko) 1989-12-15
SU1681728A3 (ru) 1991-09-30
PT90622A (pt) 1989-11-30

Similar Documents

Publication Publication Date Title
DE68902358D1 (de) Aromatische und heterocyclische carboxamide als antineoplastische mittel.
DK143986A (da) 1,2-benzisoxazol-3-yl- og 1,2-benzisothiazol-3-yl-derivater
DK173486D0 (da) Heterocykliske amidderivater
DE68927417D1 (de) Oligoribonukleotid-Derivate und ihre Anwendung als antivirale Mittel
FI970112A0 (fi) Helico-bakeerin vastaisia atsolonien asyylijohdannaisia
DE3671434D1 (de) Phenylalaninderivate und proteinaseinhibitor.
DE3769122D1 (de) Nitro-derivate von 2-iminoimidazolidinen und 2-iminotetrahydropyrimidinen.
DE69030030D1 (de) 4-Acyloxychinolin-Derivate und diese enthaltende insektizide und akarizide Mittel
DE3875866D1 (de) Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie.
DE68926733D1 (de) Piperidin-Derivate und diese enthaltende Hypotensiva
DE68909501D1 (de) Hydroxyalkylcystein-derivate und diese enthaltende expectoranzien.
DK455288D0 (da) Acylderivater
FI894798A7 (fi) Uudet 1,4-bentsoksatsiini- ja 1,4-bentsotiatsiinijohdannaiset ja menet elmä niiden valmistamiseksi
DE3782636D1 (de) Isoindolin-1-on-derivat und antiarrhythmisches mittel.
EP0716856A3 (de) Therapeutische Anwendungen von 2',5'-Oligoadenylat-Derivaten
DK722988A (da) Acylderivater
FI893648A7 (fi) Hydroksipyrimidiinien asyylijohdannaisia
DE3671630D1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
DE68919512D1 (de) Chinoxalin-Derivate und antiulzerierendes Mittel.
DE59009786D1 (de) Temperatur- und versorgungsspannungsunabhängige Multivibratorschaltung.
DE3852245D1 (de) Isoprenderivate und diese enthaltende Anti-Ulcus-Mittel.
DE3769332D1 (de) Derivate von pyrido-menadion-additionsprodukten und verwendungen davon.
DE3688032D1 (de) Amidderivate und diese enthaltende 5-lipoxygenase-inhibitoren.
FI950303L (fi) Pyridoindolobentsodiatsepiinit ja johdannaiset antipsykoottisina aineina
DE69123168D1 (de) Piperidinderivate und diese enthaltende Antiulcer-Präparate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee